Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.980
-0.010 (-0.25%)
At close: Jan 16, 2026, 4:00 PM EST
4.029
+0.049 (1.23%)
After-hours: Jan 16, 2026, 7:59 PM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $704.61 million as of January 16, 2026. Its market cap has increased by 89.12% in one year.
Market Cap
704.61M
Enterprise Value
609.46M
1-Year Change
89.12%
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $704.61M, a decrease of -56.70%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 704.61M | 14.70% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |